) on Thursday reported a 11% year-on-year jump in its net profit for the quarter ended September 2023 at Rs 216 crore, led by market share gains of its key brands.Revenue from operations rose 5% YoY to Rs 953 crore. The EBITDA margins stood at 30.1% in Q2FY24.
Our Q2 performance reflects an overall recovery with market share gains in several key promoted brands across all business units. We held leadership position for our key brands in relevant therapy areas such as anti-infectives and dermatology,” said Bhushan Akshikar, MD of GSK India
“Our focus in the coming quarters will remain on strong volume led performance in general medicines and paediatric vaccines. We will also explore innovative solutions using omni channel strategy to expand our reach and coverage to our segments,” Akshikar added.
(What’s moving Sensex
Track latest market news
, stock tips
and expert advice
. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds
Download The Economic Times News App to get Daily Market Updates & Live Business News.
Top Trending Stocks: Sensex Today Live, SBI Share Price, Axis Bank Share Price, HDFC Bank Share Price, Infosys Share Price, Wipro Share Price, NTPC Share Price